Edition:
United Kingdom

Arcturus Therapeutics Ltd (ARCT.OQ)

ARCT.OQ on NASDAQ Stock Exchange Global Market

7.75USD
26 Apr 2019
Change (% chg)

$-0.04 (-0.51%)
Prev Close
$7.79
Open
$7.79
Day's High
$7.79
Day's Low
$7.75
Volume
1,023
Avg. Vol
12,850
52-wk High
$10.00
52-wk Low
$4.11

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 7.58 -0.100
Sep '18 3.42 -0.421
Jun '18 2.39 -0.989
Mar '18 2.37 -0.654
FY 2017 Dec '17 2.02 -0.854
Sep '17 3.30 -1.513
Jun '17 3.76 -0.541
Mar '17 3.92 -0.663
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 4 3.07 4.04 1.90 --
Quarter Ending Sep-19 4 3.00 4.14 1.50 --
Year Ending Dec-19 4 12.29 16.35 6.80 0.00
Year Ending Dec-20 4 20.62 50.00 2.50 --
Earnings (per share)
Quarter Ending Jun-19 4 -0.54 -0.47 -0.66 --
Quarter Ending Sep-19 4 -0.56 -0.50 -0.68 --
Year Ending Dec-19 4 -2.34 -2.12 -2.69 -1.81
Year Ending Dec-20 4 -2.07 -1.58 -2.39 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 107.11 59.93
P/E High - Last 5 Yrs. -- 164.21 56.01
P/E Low - Last 5 Yrs. -- 52.58 28.53
Beta 2.20 1.14 0.93
Price to Sales (TTM) 5.32 45.82 9.40
Price to Book (MRQ) 6.12 13.07 4.47
Price to Tangible Book (MRQ) 6.15 18.54 7.66
Price to Cash Flow (TTM) -- 71.40 41.57
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.09 1.55
Dividend Yield - 5 Year Avg -- 0.05 0.63
Dividend 5 Year Growth Rate -- 0.75 2.95
Payout Ratio(TTM) -- 8.77 20.21

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 275.10 22.98 9.45
Sales (TTM) vs TTM 1 Yr. Ago 21.20 63.52 7.98
Sales - 5 Yr. Growth Rate -- 33.16 10.75
EPS (MRQ) vs Qtr. 1 Yr. Ago 88.27 -92.68 111.03
EPS (TTM) vs TTM 1 Yr. Ago 39.37 -- --
EPS - 5 Yr. Growth Rate -- 21.60 7.46
Capital Spending - 5 Yr. Growth Rate 106.88 25.09 8.69

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.84 2.66
Current Ratio (MRQ) 3.33 3.71 3.63
LT Debt to Equity (MRQ) 72.65 7.45 13.57
Total Debt to Equity (MRQ) 72.65 20.69 17.29
Interest Coverage (TTM) -172.00 10.34 7.27

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 25.25 50.48
Gross Margin - 5 Yr. Avg. -- 59.86 50.93
EBITD Margin (TTM) -134.13 -- --
EBITD - 5 Yr. Avg -171.94 -12.32 15.78
Operating Margin (TTM) -138.46 -111.46 -2.24
Operating Margin - 5 Yr. Avg. -175.20 -27.87 11.09
Pre-Tax Margin (TTM) -138.29 -112.18 -2.99
Pre-Tax Margin - 5 Yr. Avg. -175.99 -30.44 16.29
Net Profit Margin (TTM) -138.29 -118.54 -6.79
Net Profit Margin - 5 Yr. Avg. -176.14 -35.59 11.42
Effective Tax Rate (TTM) -- 19.88 21.80
Effective Tax Rate - 5 Yr. Avg. -- 19.63 23.48

Efficiency

  Company industry sector
Revenue/Employee (TTM) 218,792 8,643,452 760,272,784
Net Income/Employee (TTM) -302,569 1,854,167 87,478,246
Receivable Turnover (TTM) 6.35 2.49 5.20
Inventory Turnover (TTM) -- 2.43 3.68
Asset Turnover (TTM) 0.33 0.33 0.80

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -45.28 6.42 9.59
Return on Assets - 5 Yr. Avg. -41.80 6.18 10.47
Return on Investment (TTM) -60.01 8.08 11.86
Return on Investment - 5 Yr. Avg. -49.34 8.08 13.36
Return on Equity (TTM) -91.85 8.26 12.88
Return on Equity - 5 Yr. Avg. -55.54 9.16 14.85
  1 Year 3 Year 5 Year
Sales % 21.20 -- --
EPS (TTM) % 38.74 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Arcturus Therapeutics Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 15.08%
# of Holders: 24
Total Shares Held: 1,623,054
3 Mo. Net Change: 61,097
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 2
# Reduced Positions: 0
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.